Atlas Trials

A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Japanese Participants With Parkinson's Disease

Clinical trial NCT03716570 · TERMINATED

Trial details

NCT number
NCT03716570
Sponsor
Biogen
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Parkinson's Disease
Start date
2019-03-12
Primary completion
2021-04-23
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.